Euroafrica Digital Ventures AB (publ)

Euroafrica Digital Ventures AB (publ)

EURA.ST
Euroafrica Digital Ventures AB (publ)SE flagStockholm Stock Exchange
0.08
SEK
-0.01
- -
5.82MMarket Cap
Euroafrica Digital Ventures AB (publ)
EURA.ST
(Stockholm Stock Exchange)

Recent

price

0.08

P/E

ratio

- -

div

yld

- -

ROIC.AI

2019
2020
2021
2022
2023
TTM
FRC
- -
1.15
0.73
0.43
0.26
0.43
Revenue per Share
-0.01
0.01
-0.4
-0.37
-0.29
-0.31
Basic EPS, GAAP
- -
-0.01
-0.38
-0.24
-0.06
-0.15
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.01
- -
0.69
0.02
0.02
- -
Book Value per Share
0.03
-0.18
0.05
-0.08
-0.2
-0.11
Tangible Book Value per Share
19
19
32
63
73
53
Basic Weighted Avg Shares
- -
21
24
27
19
23
Sales/Revenue/Turnover
- -
2.31
-53.62
-83.89
-112.41
-69.96
Operating Margin (%)
- -
- -
4
7
8
8
Depreciation Expense
- -
- -
-13
-23
-21
-16
Net Income, GAAP
- -
19.29
- -
- -
- -
- -
Effective Tax Rate (%)
- -
1.3
-54.46
-85.34
-113.35
-72.31
Profit Margin (%)
- -
-3
2
-3
-3
2
Working Capital
- -
- -
- -
- -
- -
- -
LT Debt
1
1
34
21
- -
17
Total Equity
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
66.48
- -
- -
- -
- -
Return on Capital (%)
- -
- -
-114.94
-197.94
-1,550.95
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Dec'22
Mar'23
Jun'23
ST Debt
2
1
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
63
63
63
Market Capitalization
16
18
12

Working Capital

FRC

in mil. unless spec.
Dec'22
Mar'23
Jun'23
Total Current Assets
10
6
9
Cash, Cash Equivalents & STI
5
3
6
Accounts Receivable, Net
3
1
2
Inventories
- -
- -
- -
Total Current Liabilities
13
8
7
Payables & Accruals
- -
- -
- -
ST Debt
2
1
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-98.67%
Free Cash Flow
- -
- -
-73.18%
Net Income, GAAP
- -
- -
-9.05%
Sales/Revenue/Turnover
- -
- -
-31.53%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
6
7
7
7
27
2023
4
4
- -
- -
19
2024
5
7
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
-0.22
-0.22
-0.16
- -
-0.37
2023
- -
-0.06
- -
- -
-0.29
2024
-0.03
-0.02
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
Business
Euroafrica Digital Ventures AB (publ) (EURA.ST), now operating as Deversify Health AB following a reverse acquisition by Deversify AB completed on August 1, 2024, develops and commercializes health technology solutions focused on metabolic health monitoring and education; its main products include Acetrack, a mobile electronic ketone breathalyzer that measures ketosis levels for consumers, businesses, and healthcare providers, and Elitista, a digital health education platform offering personalized coaching and tools for metabolic health improvement. The company, founded in 2016 as Deversify and headquartered in Uppsala, Sweden, targets global consumer markets (B2C) through direct e-commerce sites like getacetrack.com and elitista.se, as well as B2B2C channels via partnerships, resellers, and distributors in Europe, the United States, Canada, Australia, New Zealand, South Korea, and other regions. Previously a digital media technology firm with SaaS platforms for media planning, campaign optimization, publishing, and performance monitoring, along with operations in Tanzania's online marketplace Kupatana, the company underwent a major strategic shift in 2024, including the divestment of legacy subsidiaries such as Kupatana AB, Social Content AB, and Afrieuro Digital Ventures Ltd., a name change effective August 2, 2024, a ticker symbol update to DEV, conditional Nasdaq First North Growth Market listing approval, and a rights issue of units raising approximately SEK 43.8 million before costs to fund debt repayment, working capital, marketing, business development, and product expansion.